These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Rituximab for the treatment of high titre inhibitors in mild haemophilia A. Dolničar MB; Rajić V; Kitanovski L; Debeljak M Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s345-7. PubMed ID: 23522890 [No Abstract] [Full Text] [Related]
10. Failure of rituximab to induce immune tolerance in a boy with severe haemophilia A and an alloimmune factor VIII antibody: a case report and review of the literature. Biss TT; Velangi MR; Hanley JP Haemophilia; 2006 May; 12(3):280-4. PubMed ID: 16643214 [TBL] [Abstract][Full Text] [Related]
11. Effectiveness of high-dose intravenous gamma globulin therapy in acquired von Willebrand's disease. van Genderen PJ; Michiels JJ; Bakker JJ; van 't Veer MB Vox Sang; 1994; 67(1):14-7. PubMed ID: 7975445 [TBL] [Abstract][Full Text] [Related]
12. Acquired hemophilia in the patient suffering from rheumatoid arthritis: case report. Drobiecki A; Pasiarski M; Hus I; Sokołowska B; Wątek M Blood Coagul Fibrinolysis; 2013 Dec; 24(8):874-80. PubMed ID: 24042266 [TBL] [Abstract][Full Text] [Related]
13. Twelve years of experience of acquired hemophilia A: trials and tribulations in South Australia. Tay L; Duncan E; Singhal D; Al-Qunfoidi R; Coghlan D; Jaksic W; Szabo F; McRae S; Lloyd J Semin Thromb Hemost; 2009 Nov; 35(8):769-77. PubMed ID: 20169513 [TBL] [Abstract][Full Text] [Related]
14. Control of life-threatening head and neck hemorrhage after dental extractions: a case report. Lieberman BL; Kennedy MK; Lorenzo DR; Reed LJ; Adamo AK; Cardo VA; Badner VM J Oral Maxillofac Surg; 2010 Sep; 68(9):2311-9. PubMed ID: 20728036 [No Abstract] [Full Text] [Related]
15. [Long-term response to rituximab in a patient with acquired hemophilia]. García-Chávez J; Vela-Ojeda J; García-Manzano A; Majluf-Cruz A Rev Invest Clin; 2011; 63(2):210-2. PubMed ID: 21717725 [TBL] [Abstract][Full Text] [Related]
16. B-cell depletion with rituximab as treatment for immune hemolytic anemia and chronic thrombocytopenia. Zaja F; Iacona I; Masolini P; Russo D; Sperotto A; Prosdocimo S; Patriarca F; de Vita S; Regazzi M; Baccarani M; Fanin R Haematologica; 2002 Feb; 87(2):189-95. PubMed ID: 11836170 [TBL] [Abstract][Full Text] [Related]
17. Recombinant FVIIa in the treatment of bleeding in acquired hemophilia. Guerin V; Chossat I; Dutronc H; Dubreuil M; Valentin F Am J Hematol; 2002 Aug; 70(4):333. PubMed ID: 12210820 [No Abstract] [Full Text] [Related]
18. Acquired hemophilia A: clinical features, surgery and treatment of 34 cases, and experience of using recombinant factor VIIa. Lak M; Sharifian RA; Karimi K; Mansouritorghabeh H Clin Appl Thromb Hemost; 2010 Jun; 16(3):294-300. PubMed ID: 19211581 [TBL] [Abstract][Full Text] [Related]
19. Rituximab for the treatment of patients with very high-titre acquired factor VIII inhibitors refractory to conventional chemotherapy. Field JJ; Fenske TS; Blinder MA Haemophilia; 2007 Jan; 13(1):46-50. PubMed ID: 17212724 [TBL] [Abstract][Full Text] [Related]
20. Acquired von Willebrand syndrome: an underdiagnosed and misdiagnosed bleeding complication in patients with lymphoproliferative and myeloproliferative disorders. Federici AB Semin Hematol; 2006 Jan; 43(1 Suppl 1):S48-58. PubMed ID: 16427386 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]